Political Determinants of Health: What the UN Setback Signals for NCD Action

Political Determinants of Health:
What the UN Setback Signals for NCD Action

 

Dr. José M. Zuniga, President/CEO, Fast-Track Health

The world’s leaders convened in New York City last week for the Fourth UN High-Level Meeting on Noncommunicable Diseases (NCDs) and Mental Health. The gathering was billed by the United Nations (UN) as a critical inflection point: halfway to 2030, the global community was supposed to renew commitments to bend the rising curve of chronic disease and mental health burdens. Yet despite broad support, the Political Declaration on the Prevention and Control of Noncommunicable Diseases and the Promotion of Mental Health and Wellbeing failed to secure formal endorsement at the High-Level Meeting.

Although dozens of presidents, prime ministers, and health ministers from across blocs praised the draft declaration, adoption by consensus collapsed when the United States objected to its inclusion. In the High-Level Meeting, US Health Secretary Robert F. Kennedy, Jr., denounced the draft as “exceed[ing] the UN’s proper role,” referring especially to proposals around taxation of unhealthy products and references to gender perspectives. This objection means the declaration could not simply be adopted by consensus and must now be put to a formal vote in the UN General Assembly.

Even before the US veto, intense negotiations had already watered-down stronger policy language in response to corporate and ideological pushback. Measures like taxes on tobacco, alcohol, and sugary beverages were weakened or removed in the final text. Many health advocates saw this as a lost opportunity: these kinds of “sin taxes” are among the most evidence-backed tools to reduce consumption of harmful products. More broadly, the drafting process exposed how states must constantly navigate commercial pressures, ideological objections, and sovereignty concerns while trying to preserve substantive ambition.

The breakdown of public health leadership at the High-Level Meeting exposes the political determinants of health, notably the ways power, governance, ideology, and vested interests impact public health outcomes. Even when epidemiological consensus is firm, the translation into binding political commitments is fragile. The US objection underscores how a single actor with economic and diplomatic heft can block collective action. That dynamic weakens confidence in multilateral health governance and signals to less powerful countries that their struggles or calls for bold policy can be overruled.

The matter is not mere political trivia. Cardiovascular disease, cancers, diabetes, and chronic respiratory disease already account for over 43 million deaths annually, or roughly 75% of non-pandemic deaths worldwide. The toll falls disproportionately on low- and middle-income countries, where health systems are least equipped to deliver prevention, early detection, and continuous care. Without urgent action, the growing burden of NCDs threatens to reverse hard-won gains in life expectancy and sustainable development.

The cost for inaction is not only tragic; it is deeply inefficient. In its latest report, Saving Lives, Spending Less: The Global Investment Case for Noncommunicable Diseases, the World Health Organization (WHO) estimates that an additional investment of just US $3 per person annually could generate up to US $1 trillion in economic benefits by 2030. That figure captures productivity gains, avoided health care costs, and broader economic multiplier effects. In short: it is one of the best returns on investment available to global health.

These gains come through scaling up WHO’s “best buys” – cost-effective interventions such as taxation of unhealthy products, reductions in salt consumption, tobacco control, and better hypertension detection and control. The 2025 WHO report warns that progress on NCD mortality is already slowing, meaning every delay increases cumulative harm. Implementing these proven measures now is not just a health imperative but also an economic necessity, as each year of inaction compounds both lives lost and costs incurred.

Moreover, the narrative shift that WHO has urged is critical: NCDs should not be thought of as inevitable or merely a budget burden, but rather as preventable threats and smart investments in human capital. Thus, the failure to endorse the Political Declaration’s at the High-Level Meeting is more than symbolic. It weakens the normative impetus for countries to adopt and finance bold NCD strategies, invites further watering down of commitments, and reinforces the message that health is still subordinate to politics and corporate interests.

What Fast-Track Health Believes Must Happen Next

  • Mobilize civil society and academic pressure: Health advocates, researchers, and patient groups must spotlight this failure and demand accountability, ensuring the forthcoming vote is not merely procedural but substantive.
  • Expose and counter industry interference: The same commercial actors that lobbied for softer language must be publicly held to account. Transparent disclosures of influence are essential.
  • Focus on national-level champions: Even if the global declaration is delayed, countries must not wait. National governments must push forward with tobacco, sugar, and alcohol taxes, regulatory standards, and primary care integration.
  • Strengthen multilateral health governance: The U.N. and WHO must revisit how to ensure binding decision-making in health, even when powerful states object, so that science does not get vetoed by politics.
  • Reconnect with the investment narrative: Emphasize that NCD action is not a cost but an engine for sustainable development. The US $3 per person example shows that this is not aspirational; it is feasible.

The US-provoked public health leadership breakdown at the High-Level Meeting should serve as a cautionary signal, not a reason for despair. It highlights that the greatest obstacles in global health are increasingly political, not technical. For Fast-Track Health and the broader global health ecosystem, this moment must be a pivot to make NCD advocacy not just epidemiologically compelling, but politically irresistible.